- Home
- INAB vs HBIO Comparison
INAB vs HBIO Comparison
Compare INAB & HBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INAB
- HBIO
- Stock Information
- Founded
- INAB 2016
- HBIO 1901
- Country
- INAB United States
- HBIO United States
- Employees
- INAB N/A
- HBIO N/A
- Industry
- INAB Biotechnology: Pharmaceutical Preparations
- HBIO Biotechnology: Laboratory Analytical Instruments
- Sector
- INAB Health Care
- HBIO Industrials
- Exchange
- INAB Nasdaq
- HBIO Nasdaq
- Market Cap
- INAB 18.8M
- HBIO 16.9M
- IPO Year
- INAB 2021
- HBIO 2000
- Fundamental
- Price
- INAB $0.19
- HBIO $0.39
- Analyst Decision
- INAB Strong Buy
- HBIO Buy
- Analyst Count
- INAB 2
- HBIO 2
- Target Price
- INAB $3.60
- HBIO $4.50
- AVG Volume (30 Days)
- INAB 786.0K
- HBIO 349.2K
- Earning Date
- INAB 05-08-2025
- HBIO 05-06-2025
- Dividend Yield
- INAB N/A
- HBIO N/A
- EPS Growth
- INAB N/A
- HBIO N/A
- EPS
- INAB N/A
- HBIO N/A
- Revenue
- INAB N/A
- HBIO $94,135,000.00
- Revenue This Year
- INAB N/A
- HBIO N/A
- Revenue Next Year
- INAB N/A
- HBIO $8.58
- P/E Ratio
- INAB N/A
- HBIO N/A
- Revenue Growth
- INAB N/A
- HBIO N/A
- 52 Week Low
- INAB $0.13
- HBIO $0.36
- 52 Week High
- INAB $1.74
- HBIO $4.08
- Technical
- Relative Strength Index (RSI)
- INAB 49.14
- HBIO 31.60
- Support Level
- INAB $0.15
- HBIO $0.56
- Resistance Level
- INAB $0.18
- HBIO $0.42
- Average True Range (ATR)
- INAB 0.02
- HBIO 0.06
- MACD
- INAB 0.01
- HBIO 0.02
- Stochastic Oscillator
- INAB 93.22
- HBIO 24.08
About INAB IN8bio Inc.
IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of gamma-delta T cell product candidates for solid and liquid tumors, by employing allogeneic, autologous, and genetically modified gamma-delta T cells. Its product candidates include INB-400, for the treatment of newly diagnosed glioblastoma, or GBM, INB-100 for the treatment of patients with high-risk leukemias undergoing hematopoietic stem cell transplantation, and other product candidates such as INB-200, INB-300, and INB-500.
About HBIO Harvard Bioscience Inc.
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, Multichannel Systems MCS GmbH, and Panlab.. The majority of its revenue comes from the United States.